Cargando…
Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945251/ https://www.ncbi.nlm.nih.gov/pubmed/36574215 http://dx.doi.org/10.1097/CM9.0000000000002503 |
| _version_ | 1784892099407118336 |
|---|---|
| author | Fan, Lina Li, Lei Gao, Liying Hu, Yue Yu, Aiping Zhang, Defa Qiu, Chunting Huang, Rong Wu, Yue Ma, Ping |
| author_facet | Fan, Lina Li, Lei Gao, Liying Hu, Yue Yu, Aiping Zhang, Defa Qiu, Chunting Huang, Rong Wu, Yue Ma, Ping |
| author_sort | Fan, Lina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9945251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99452512023-02-23 Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome Fan, Lina Li, Lei Gao, Liying Hu, Yue Yu, Aiping Zhang, Defa Qiu, Chunting Huang, Rong Wu, Yue Ma, Ping Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-11-20 2022-12-27 /pmc/articles/PMC9945251/ /pubmed/36574215 http://dx.doi.org/10.1097/CM9.0000000000002503 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Fan, Lina Li, Lei Gao, Liying Hu, Yue Yu, Aiping Zhang, Defa Qiu, Chunting Huang, Rong Wu, Yue Ma, Ping Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome |
| title | Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome |
| title_full | Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome |
| title_fullStr | Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome |
| title_full_unstemmed | Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome |
| title_short | Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome |
| title_sort | advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945251/ https://www.ncbi.nlm.nih.gov/pubmed/36574215 http://dx.doi.org/10.1097/CM9.0000000000002503 |
| work_keys_str_mv | AT fanlina advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT lilei advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT gaoliying advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT huyue advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT yuaiping advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT zhangdefa advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT qiuchunting advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT huangrong advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT wuyue advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT maping advantagesofswitchingtoelvitegravircobicistatemtricitabinetenofovirtherapyinvirologicallysuppressedpeoplelivingwithhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome |